MEDICAL ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2026-03-21 My2014 来自广东省

投稿命中率:25.0
偏重的研究方向：医学;肿瘤
经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。

14 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2025-12-17 ms6000000270780569 来自广西

一个月了还在with editor ，啥情况？

43 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2025-07-04 gullllll 来自安徽省

审稿速度:3.0 | 投稿命中率:75.0
偏重的研究方向：乳腺癌
经验分享：3.12投出、6.4接收、6.25见刊
中间就返修了一次，总体来说还不错

108 7 举报

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2023-02-20 咪小宝来自安徽省

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：肿瘤
经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业

226 16 举报

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2017-06-18 306118416_72492654

投稿十天仍然是Editor Assignment Pending状态

375 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2023-06-12 yzhdx 来自广西

丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫

180 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2024-04-05 1240a43am62暂无昵称来自重庆

请问这个杂志接收到proof需要多久，快3周了还还消息。

182 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2023-11-04 WX631576466 来自广西

我有endnotes 格式，可以无偿查重，需要找我

0 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2024-10-28 ms3000001851671973 来自湖北省

偏重的研究方向：肿瘤
经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。

126 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2304592, encodeId=d2102304592f3, content=投稿命中率:25.0 偏重的研究方向：医学;肿瘤 经验分享：with editor状态已70天，一直拖着，发邮件咨询了，第一次回复了，但状态无更新，第二次再咨询，也不回复了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=14, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=510a106574, createdName=My2014, createdTime=Sat Mar 21 18:39:50 CST 2026, time=2026-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2293615, encodeId=0dfe229361541, content=一个月了还在with editor ，啥情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5e028335127, createdName=ms6000000270780569, createdTime=Wed Dec 17 20:31:18 CST 2025, time=2025-12-17, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2272068, encodeId=b41922e20688b, content=审稿速度:3.0 | 投稿命中率:75.0 偏重的研究方向：乳腺癌 经验分享：3.12投出、6.4接收、6.25见刊 中间就返修了一次，总体来说还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3e89576080, createdName=gullllll, createdTime=Fri Jul 04 17:50:11 CST 2025, time=2025-07-04, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2115612, encodeId=902621156126d, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：肿瘤 经验分享：第一篇，6.20-8.18出版第二篇，11.21-2.20接收总的来说，我觉得这个杂志速度挺快的，审稿专家提的问题也很专业, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=226, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0d015545609, createdName=咪小宝, createdTime=Mon Feb 20 23:27:20 CST 2023, time=2023-02-20, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=538178, encodeId=d1fd5381e8ac, content=投稿十天仍然是Editor Assignment Pending状态, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c6ef2072786, createdName=306118416_72492654, createdTime=Sun Jun 18 18:08:00 CST 2017, time=2017-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142418, encodeId=a869214241855, content=丫的，一个半月了，发邮件问状态，它说编辑还没有初审。简直麻了，学位证还要靠它呢，希望渺茫, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=180, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=98ae5567086, createdName=yzhdx, createdTime=Mon Jun 12 19:58:25 CST 2023, time=2023-06-12, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2197033, encodeId=f3ba219e0334f, content=请问这个杂志接收到proof需要多久，快3周了还还消息。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200826/bbc61687fab64e71b236e41ce01103f8/8663b492335744f1b226bbfd943715de.jpg, createdBy=a4622456608, createdName=1240a43am62暂无昵称, createdTime=Fri Apr 05 12:47:32 CST 2024, time=2024-04-05, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2166694, encodeId=0696216669412, content=我有endnotes 格式，可以无偿查重，需要找我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20230615/d755758c7e4e45b2860dd0db9a9c8a5f/d51b884347bd432b8ceba4bc8728fb21.jpg, createdBy=41b65550607, createdName=WX631576466, createdTime=Sat Nov 04 21:19:43 CST 2023, time=2023-11-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2233556, encodeId=c47e22335567b, content=偏重的研究方向：肿瘤 经验分享：请问大家新投的审稿速度怎么样？投了十天了没有反应。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80858144869, createdName=ms3000001851671973, createdTime=Mon Oct 28 06:37:20 CST 2024, time=2024-10-28, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2224751, encodeId=6c3b2224e5154, content=鼻咽癌方面的meta分析三天被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4c5a9454431, createdName=ms3000000258454181, createdTime=Mon Sep 09 09:15:06 CST 2024, time=2024-09-09, status=1, ipAttribution=上海)]

2024-09-09 ms3000000258454181 来自上海

鼻咽癌方面的meta分析三天被拒

108 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务